The adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Martine Dehlinger-Kremer, PhD
Advertisement
Articles by Martine Dehlinger-Kremer, PhD
Successful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Current Status of European Research Related to COVID-19: The EUCROF PerspectivePublished: January 25th 2021 | Updated:
COVID-19 Pandemic Exemplifies the Benefits of CROsPublished: May 24th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Streamlining Clinical Data to Reduce Site and Participant Burden
3
ACT Brief: Lilly Seeks FDA Priority Review for Oral GLP-1 as Bispecific Antibody Trials Redefine Ethical Standards
4
2025 SCRS Global Site Solutions Summit Recap: Moving to True Partnerships
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
